Ironwood Pharmaceuticals, Inc.
IRWD
$0.7267
-$0.0233-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.26M | 3.65M | -860.00K | -4.16M | -1.09M |
| Total Depreciation and Amortization | 485.00K | 907.00K | 106.00K | 513.00K | 512.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.09M | 15.97M | 22.81M | 15.06M | 44.95M |
| Change in Net Operating Assets | -33.61M | -10.63M | 11.41M | 33.58M | -8.55M |
| Cash from Operations | 15.21M | 9.89M | 33.47M | 44.99M | 35.83M |
| Capital Expenditure | 0.00 | -16.00K | -58.00K | -68.00K | -211.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -3.98M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -16.00K | -58.00K | -68.00K | -4.19M |
| Total Debt Issued | 0.00 | 0.00 | 150.00M | -- | 0.00 |
| Total Debt Repaid | -15.00M | -25.00M | -200.00M | -25.00M | -25.00M |
| Issuance of Common Stock | 203.00K | 0.00 | 749.00K | 10.06M | 998.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | -121.00K | -616.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -90.00K | -2.16M | -- | -- | -26.90M |
| Cash from Financing | -14.89M | -27.16M | -49.37M | -15.56M | -50.90M |
| Foreign Exchange rate Adjustments | 21.00K | -26.00K | -51.00K | 24.00K | -50.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 348.00K | -17.31M | -16.02M | 29.39M | -19.31M |